PUBLICATIONS · 32888407
Lisocabtagene maraleucel for patients with relapsed or refractory large B-cell lymphomas (TRANSCEND NHL 001): a multicentre seamless design study.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- Lancet
- Publication date
- 2020 Sep 19
- First author
- Abramson JS
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- citation
- Nat Rev Clin Oncol. 2020 Nov;17(11):654. doi: 10.1038/s41571-020-00435-3.
- note
- Source null
- related pmid
- 32958956
- relationship
- Comment in
Authors and identifiers
- name
- Abramson JS
- type
- Author
- name
- Palomba ML
- type
- Author
- name
- Gordon LI
- type
- Author
- name
- Lunning MA
- type
- Author
- name
- Wang M
- type
- Author
- name
- Arnason J
- type
- Author
- name
- Mehta A
- type
- Author
- name
- Purev E
- type
- Author
- name
- Maloney DG
- type
- Author
- name
- Andreadis C
- type
- Author
- name
- Sehgal A
- type
- Author
- name
- Solomon SR
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Abramson JS
- type
- Author
- name
- Palomba ML
- type
- Author
- name
- Gordon LI
- type
- Author
- name
- Lunning MA
- type
- Author
- name
- Wang M
- type
- Author
- name
- Arnason J
- type
- Author
- name
- Mehta A
- type
- Author
- name
- Purev E
- type
- Author
- name
- Maloney DG
- type
- Author
- name
- Andreadis C
- type
- Author
- name
- Sehgal A
- type
- Author
- name
- Solomon SR
- type
- Author
- bibliography ids
- nci-bib-61f72984cfb1f5d53c552e85
- book metadata
- content sha256
- 9d5537f2b988b40deabbe2fbcf1a036db754df323fbd26f37451025bad553cc7
- document type
- citation
- dois
- 10.1016/S0140-6736(20)31366-0
- electronic publication date
- display
- 2020 Sep 1
- precision
- day
- year
- 2020
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:32888407
- immutable id
- pubmed:32888407@9d5537f2b988b40deabbe2fbcf1a036db754df323fbd26f37451025bad553cc7
- journal
- abbreviation
- Lancet
- issn electronic
- 1474-547X
- issn print
- 0140-6736
- issue
- 10254
- name
- Lancet (London, England)
- nlm unique id
- 2985213R
- pages
- 839-852
- volume
- 396
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- citation
- Nat Rev Clin Oncol. 2020 Nov;17(11):654. doi: 10.1038/s41571-020-00435-3.
- note
- Source null
- related pmid
- 32958956
- relationship
- Comment in
- outcomes validated
- false
- pmid
- 32888407
- provenance
- batch id
- 9bca82d1bba2b27adc79
- provider
- NCBI PubMed ESummary
- record sha256
- afdd956af04399b25bffe88a8cb985074f88d14c6b98787c815635a33378fe33
- response sha256
- c8a4853c65a45038af15f5ade3970763bfa121cf5c68bafcc52c3a06860d0211
- retrieved at
- 2026-09-09T23:47:56.131551+00:00
- publication date
- display
- 2020 Sep 19
- precision
- day
- year
- 2020
- publication types
- Clinical Trial
- Journal Article
- Multicenter Study
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Lisocabtagene maraleucel for patients with relapsed or refractory large B-cell lymphomas (TRANSCEND NHL 001): a multicentre seamless design study.
Preserved source evidence · Independent clinical review pending · Not medical advice
Triangle